drugset / Trial / NCT01257984

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

NCT01257984

Phase 3 Completed 508 enrolled Bayer
RandomizedSingle-groupOpen-labelTreatment

Summary

The objective of the study is to evaluate the effect of the dispenser's buzzer function on compliance with daily tablet intake of an ethinyl estradiol (EE) + drospirenone (DRSP) containing oral contraceptive (OC) in a flexible extended regimen when administered for approximately 12 months to healthy female volunteers who request contraception.

Timeline

Start
2010-12
Primary completion
2012-08
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Background drospirenone Unknown 3 mg Oral
Background ethinyl estradiol Small molecule 0.02 mg Oral

Indications

No indication recorded.